Lusayan, Lhia B.
HRN: 22-57-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/13/2024
07/19/2024
IV
2.25g
Q8
CAP-HR; PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes